Risk distribution and its influence on the population targets for diabetes prevention

Preventive Medicine

Volumn 58, Issue 1, 2014, Pages 17-21

  Rosella, Laura C ^a,b,c   Lebenbaum, Michael ^a   Li, Ye ^a,c   Wang, Jun ^a   Manuel, Douglas G ^a,b,d,e,f  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f STATISTICS CANADA   (Canada)

Author keywords

Diabetes mellitus, type 2; Primary prevention; Risk assessment

Indexed keywords

ARTICLE; BODY MASS; CANADA; DIABETES MELLITUS; ETHNICITY; HUMAN; HYPERTENSION; IMMIGRANT; OBESITY; POPULATION RISK; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

ABSOLUTE RISK REDUCTION; ARR; CANADIAN COMMUNITY HEALTH SURVEY; CCHS; DIABETES MELLITUS, TYPE 2; DIABETES POPULATION RISK TOOL; DPORT; PRIMARY PREVENTION; RISK ASSESSMENT;

ADULT; AGED; ALGORITHMS; CANADA; COMMUNITY HEALTH SERVICES; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUMBERS NEEDED TO TREAT; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84890186301     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.10.007     Document Type: Article

References (29)

1. Asada Y. Assessment of the health of Americans: the average health-related quality of life and its inequality across individuals and groups. Popul. Health Metrics 2005, 3:7.
2. Buijsse B., Simmons R.K., Griffin S.J., Schulze M.B. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol. Rev. 2011, 33:46-62.
3. Burke J.P., Williams K., Narayan K.M.V., Leibson C., Haffner S.M., Stern M.P. A population perspective on diabetes prevention. Diabetes Care 2003, 26:1999-2004.
4. Canadian Task Force on Preventive Health Care Recommendations on screening for type 2 diabetes in adults. Can. Med. Assoc. J. 2012, 184:1687-1696.
5. Chamnan P., Simmons R.K., Khaw K.T., Wareham N.J., Griffin S.J. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of type 2 diabetes: a modelling study. Diabet. Med. 2012, 29:893-904.
6. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary disease prediction scores. JAMA 2001, 286:180-187.
7. Furukawa T.A., Guyatt G.H., Griffith L.E. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int. J. Epidemiol. 2002, 31:72-76.
8. Gillies C.L., Abrams K.R., Cooper N.J., Hsu R.T., Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2008, 334:299.
9. Glasser G.J. Variance formulas for mean difference and coefficient of concentration. J. Am. Stat. Assoc. 1962, 57:648.
10. Glickman D., Parker L., Sim L.J., Cook H.D.V., Miller E.A. Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation 2012, The National Academies, Washington, DC.
11. Harding A.H., Griffin S.J., Wareham N.J. Population impact of strategies for identifying groups at high risk of type 2 diabetes. Prev. Med. 2006, 42:364-368.
12. Hosmer D.W., Lemenshow S. Applied Logistic Regression 2000, John Wiley & Sons.
13. Hux J.E., Ivis F. Diabetes in Ontario. Diabetes Care 2005, 25:512-516.
14. Klotsche J., Ferger D., Pieper L., Rehm J., Wittchen H.U. A novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology. BMC Med. Res. Methodol. 2009, 9:63.
15. Kovacevic M.S., Mach L., Roberts G. Bootstrap Variance Estimation for Predicted Individual and Population-average Risks 2008, American Statistical Association.
16. Manuel D.G., Rosella L.C., Tuna M., Bennett C., Stukel T.A. Effectiveness of community-wide and individual high-risk strategies to prevent diabetes: a modelling study. PLoS One 2013, 8:e52963.
17. Manuel D.G., Rosella L.C., Hennessy D., Sanmartin C., Wilson K. Predictive risk algorithms in a population setting: an overview. J. Epidemiol. Commun. Health 2012, 66:859-865.
18. McLaren L., McIntyre L., Kirkpatrick S. Rose's population strategy of prevention need not increase social inequalities in health. Int. J. Epidemiol. 2010, 39:372-377.
19. Nam B.-H. Discrimination and calibration in survival analysis: extension of the ROC curve for descrimination and chi-square test for calibration 2000, Boston University.
20. Noble D., Mathur R., Dent T., Meads C., Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. Br. Med. J. 2011, 343.
21. Pencina M., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat. Med. 2004, 23:2109-2123.
22. Ratner R.E. The imperative to prevent diabetes. Diabetes Care 2012, 35:2417-2418.
23. Rose G.A. The Strategy of Preventive Medicine 1992, Oxford University Press, New York.
24. Rosella L.C., Manuel D.G., Burchill C., Stukel T.A. A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J. Epidemiol. Community Health 2011, 65:613-620.
25. Rosella L.C., Corey P., Stukel T.A., Mustard C., Hux J., Manuel D.G. The influence of measurement error on calibration, discrimination, and overall estimation of a risk prediction model. Popul. Health Metrics 2012, 10:20.
26. Statistics Canada Population and dwelling counts, for Census Divisions, Census Subdivisions (Municipalities) and designated places, 2001 and 1996 2001, Statistics Canada, Ottawa, ON.
27. Statistics Canada Canadian Community Health Survey methodological overview. Health Rep. 2002, 13:9-14.
28. Statistics Canada Canadian community health survey 2000-2001 2003, Statistics Canada, Ottawa.
29. Tabak A.G., Herder C., Rathmann W., Brunner E.J., Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379:2279-2290.